CAH - Becton Dickinson Recalls Certain Infusion Pumps Citing Issues With Cardinal Health's Syringes | Benzinga
Friday, the FDA said that Becton, Dickinson, And Company (NYSE: BDX) is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health Inc's (NYSE: CAH) Monoject syringes.
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
The Alaris pumps are validated for use with 'Monoject' syringes. However, the dimensions for Monoject syringes have ...